Highlights NFID Releases New Resources on Influenza Immunizations of Those with Chronic Illness Updates on Vaccine Administration Tools That Are Available from CDC Cooperative Agreement Grants Open at CDC CDC Influenza Webinar on December 5 for National Influenza Vaccination Week…

Highlights Genentech Announces FDA Approval of Xofluza for the Treatment of Acute, Uncomplicated Influenza in People 12 Years of Age and Older Seqirus Receives FDA Approval of Afluria® Quadrivalent (Influenza Vaccine) for People Six Months of Age and Older in…